JP2012522994A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522994A5
JP2012522994A5 JP2012503717A JP2012503717A JP2012522994A5 JP 2012522994 A5 JP2012522994 A5 JP 2012522994A5 JP 2012503717 A JP2012503717 A JP 2012503717A JP 2012503717 A JP2012503717 A JP 2012503717A JP 2012522994 A5 JP2012522994 A5 JP 2012522994A5
Authority
JP
Japan
Prior art keywords
expression
positive control
biomarkers
mmp
regulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012503717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522994A (ja
JP5643288B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/029674 external-priority patent/WO2010115034A2/en
Publication of JP2012522994A publication Critical patent/JP2012522994A/ja
Publication of JP2012522994A5 publication Critical patent/JP2012522994A5/ja
Application granted granted Critical
Publication of JP5643288B2 publication Critical patent/JP5643288B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012503717A 2009-04-01 2010-04-01 軟組織疾患の診断のための、および口腔ケア介入のための療法的標的としてのタンパク質バイオマーカー Expired - Fee Related JP5643288B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01
US61/165,674 2009-04-01
PCT/US2010/029674 WO2010115034A2 (en) 2009-04-01 2010-04-01 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Publications (3)

Publication Number Publication Date
JP2012522994A JP2012522994A (ja) 2012-09-27
JP2012522994A5 true JP2012522994A5 (enExample) 2013-05-16
JP5643288B2 JP5643288B2 (ja) 2014-12-17

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503717A Expired - Fee Related JP5643288B2 (ja) 2009-04-01 2010-04-01 軟組織疾患の診断のための、および口腔ケア介入のための療法的標的としてのタンパク質バイオマーカー

Country Status (15)

Country Link
US (1) US8753820B2 (enExample)
EP (1) EP2414837B1 (enExample)
JP (1) JP5643288B2 (enExample)
CN (1) CN102549432B (enExample)
AR (1) AR076041A1 (enExample)
BR (1) BRPI1013184A2 (enExample)
CA (1) CA2753718C (enExample)
CO (1) CO6430490A2 (enExample)
MX (1) MX2011008439A (enExample)
MY (1) MY179250A (enExample)
RU (1) RU2523383C2 (enExample)
SG (1) SG173461A1 (enExample)
TW (1) TWI481870B (enExample)
WO (1) WO2010115034A2 (enExample)
ZA (1) ZA201106056B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076177A1 (es) * 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
WO2018129043A1 (en) * 2017-01-03 2018-07-12 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
EP3631462A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
EP3631458A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary hgf and mmp-8
US12050223B2 (en) 2017-05-24 2024-07-30 Koninklijke Philips N.V. Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
WO2019084351A1 (en) 2017-10-27 2019-05-02 The Regents Of The University Of California SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
EP0728017A1 (en) 1993-11-10 1996-08-28 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
DE29724204U1 (de) 1996-06-12 2000-09-21 Cognis Deutschland GmbH, 40589 Düsseldorf Kosmetische und/oder pharmazeutische Zubereitungen
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
PT2295968E (pt) 1999-12-03 2013-01-09 Baxter Int Teste de pirogenicidade para utilização com sistemas automatizados de imunoensaio
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
JP2003530130A (ja) 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
WO2004073614A2 (en) 2003-02-14 2004-09-02 Combinatorx, Incorporated Combination therapy for the treatment of immunoinflammatory disorders
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
JP2007514648A (ja) 2003-10-24 2007-06-07 エーザイ株式会社 Toll−likereceptor2に関連する疾患及び状態を治療するための化合物及び方法
CA2546126A1 (en) 2003-12-03 2005-06-23 Christopher Hug Use of t-cadherin as a target
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Nfat2発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP2009523029A (ja) 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
EP2207546A1 (en) 2007-10-09 2010-07-21 Humco Holding Group, Inc. Antifungal treatment of nails

Similar Documents

Publication Publication Date Title
Zheng et al. DNA methylation clocks for estimating biological age in Chinese cohorts
EA202190075A2 (ru) Анализ транскриптома материнской плазмы с применением массивного параллельного секвенирования рнк
JP2013518244A5 (enExample)
BR112015029318A2 (pt) marcadores específicos de caminhos para diagnóstico da síndrome do intestino irritável
MX2015015532A (es) Metodo y sistema de identificacion de biomarcadores.
RU2011144032A (ru) Протеиновые биомаркеры для диагностики заболевания мягких тканей и в качестве терапевтических мишеней для вмешательства в гигиену полости рта
GB2467704A (en) Methods of monitoring conditions by sequence analysis
EA201291228A1 (ru) Биомаркер для детекции высокогорной адаптации и высокогорного отека легких
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
JP2017505897A5 (enExample)
RU2011111875A (ru) Способ прогнозирования развития осложнений у больных внебольничной пневмонией
HK1225298A1 (zh) Cd6结合配对体的使用和以其为基础的方法
JP2010502979A5 (enExample)
EA201500939A1 (ru) Определение геномов плодов при многоплодных беременностях
RU2007124208A (ru) Способ оценки степени тяжести бронхиальной астмы у детей
Miller et al. Fibroblast mechanoperception instructs pulmonary developmental and pattern specification gene expression programs
RU2012144558A (ru) Способ лабораторной диагностики септической энцефалопатии у новорожденных с перинатальным гипоксическим поражением цнс
Lal et al. Early'omic'Biomarkers Predict Bronchopulmonary Dysplasia (bpd)
Kudo et al. A Simple Index to Predict Liver Functional Reserve after Hepatectomy
WO2014186361A3 (en) Pharmacogenomic biomarkers for b cell malignancies and methods of use thereof
Seumois et al. A110 LATE BREAKING ABSTRACTS IN DISEASE SUSCEPTIBILITY AND PATHOGENESIS: Epigenomic Analysis Of Primary Human T Cells Reveals Novel Enhancers Associated With Th2 Memory Differentiation And Asthma Susceptibility
RU2008139366A (ru) Способ контроля и управления системой
Fortier et al. Plasma Biomarkers Of Diffuse Parenchymal Lung Disease In Hermansky-Pudlak Syndrome
IT201900024550A1 (it) Micro-RNA circolanti come biomarcatori per la diagnosi di celiachia e per il monitoraggio dell’aderenza alla dieta senza glutine.
UA110080U (uk) Спосіб прогнозування розвитку постхолецистектомічного синдрому